Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer.

MLA

George, Thomashire A., et al. “Liposome-Encapsulated Anthraquinone Improves Efficacy and Safety in Triple Negative Breast Cancer.” Journal of Controlled Release, vol. 342, Feb. 2022, pp. 31–43. EBSCOhost, https://doi.org/10.1016/j.jconrel.2021.12.001.

APA

George, T. A., Chen, M. M., Czosseck, A., Chen, H.-P., Huang, H.-S., & Lundy, D. J. (2022). Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer. Journal of Controlled Release, 342, 31–43. https://doi.org/10.1016/j.jconrel.2021.12.001

Chicago

George, Thomashire A., Max M. Chen, Andreas Czosseck, Hsiang-Pei Chen, Hsu-Shan Huang, and David J. Lundy. 2022. “Liposome-Encapsulated Anthraquinone Improves Efficacy and Safety in Triple Negative Breast Cancer.” Journal of Controlled Release 342 (February): 31–43. doi:10.1016/j.jconrel.2021.12.001.